Cerebral Stock
Mental Health Telemedicine
Sign up today and learn more about Cerebral Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Cerebral Stock
Cerebral is a mental health telemedicine company. Cerebral offers therapy and medication for patients with mental illnesses such as anxiety or depression. Cerebral claims to offer its platform to individuals, employers, and payers.
Cerebral was founded in 2020 and is headquartered in San Francisco, California. Notable investors include SoftBank Vision Fund, WestCap, and Access Industries.
Investors
WestCap
Liquid 2 Ventures
Whatnot, Cerebral, Newfront Insurance, Swiftly, Mux, Parsley Health, Curebase
Funding History
September 2020 | $637K |
---|---|
September 2020 | $3K |
September 2020 | $875K |
September 2020 | $659K |
September 2020 | $404K |
September 2020 | $5K |
September 2020 | $5.1M |
September 2020 | $27.6M |
March 2021 | $126M |
November 2021 | $300M |
Management
Chief Executive Officer
Kyle Robertson
Chief Financial Officer
Meg Miller McKenna
Press
thehackernews - Apr, 18 2024
FTC Fines Mental Health Startup Cerebral $7 Million for Major Privacy Violationsmediapost - Apr, 18 2024
FTC Bans Cerebral From Harnessing Users' Health Data For Advertisingfiercehealthcare - Apr, 18 2024
Cerebral agrees to $7M settlement with FTC, DOJ over user data sharing, cancellation practicespharmaphorum - Apr, 18 2024
Telehealth firm Cerebral faces $7m FTC fine over privacymedcitynews - Apr, 18 2024
What Does the FTC’s $7M Fine Against Cerebral Mean for the Industry?